XENE

Xenon Pharmaceuticals
$65.78
+$0.36 (+0.55%)Jul 27, 2026
4.2NeutralMoatMint rating

MoatMint rates Xenon Pharmaceuticals (XENE) 4.2 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 0.7 out of 10.

Key metrics

The numbers that frame XENE today
Market cap
$6.36B
P/E (TTM)
-16.6
EV / FCF
-18.9
ROIC
-70.1%
Div yield
0%
Debt / equity
0.0
52wk Low
$30.00
52wk High
$72.66

XENE stock rating

How XENE scores on quality, value, growth, momentum and financial health
4.2out of 10
Neutral overallFair business, expensive priceTop 58% of ~5,000 US stocks
QualityPoor0.7/10
GrowthNeutral4.5/10
MomentumGreat8.7/10
ValueFair2.8/10
Financial HealthGreat8.6/10

Growth

Revenue and earnings trend for XENE
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about XENE
Is Xenon Pharmaceuticals a good buy?
Hold. Xenon Pharmaceuticals has excellent momentum, but poor quality makes the setup mixed. Growth looks mixed. The support signal is useful, but not decisive. We think Xenon Pharmaceuticals is selling at a high price.
What is the market capitalization of XENE?
Xenon Pharmaceuticals's market capitalization is $6.36B.
What is the P/E ratio for XENE stock?
Xenon Pharmaceuticals's current P/E ratio is -16.6.
What is the 52-week high for XENE stock?
The 52-week high for Xenon Pharmaceuticals is $72.66. The current close of $65.78 is 9.5% below that high.
What is the 52-week low for XENE stock?
The 52-week low for Xenon Pharmaceuticals is $30.00. The current close of $65.78 is 119.3% above that low.
Does XENE stock pay dividends?
Xenon Pharmaceuticals does not currently show a dividend per share in the company data.
What is the Debt / Equity ratio for XENE?
Xenon Pharmaceuticals's Debt / Equity ratio is 0.01.